NovoSource’s implants use proven technology that has produced clinical trial results. However, it outsources the manufacturing and sells directly to hospitals and surgeons
The company’s first product, a total knee replacement, should be launched by the end of the first quarter of 2013, pending FDA approval. A hip implant will follow.
NovoSource was founded by Harold Linville, former chief business development officer at Leis Medical Manufacturing; Jon May, president at Latex International; and Bradley Harris, former CEO at Upex Holdings.
More Articles on Orthopedic & Spine Devices:
57 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in October
Tornier Names David Mowry Interim President, CEO
Orthofix Announces International Launch of TrueLok Hexapod System
